IMpower133: Gene expression analysis in long-term survivors with ES-SCLC treated with first-line carboplatin and etoposide ± atezolizumab

The ESMO Virtual Plenaries are freely available to all healthcare professionals working in Oncology.

Programme

Thursday, 17 June 2021

18:15-19:15 CEST

Welcome and introduction, Scientific background and context

Luis Paz-Ares, Hospital Universitario 12 de Octubre, Madrid, Spain

IMpower133: Gene expression analysis in long-term survivors with ES-SCLC treated with first-line carboplatin and etoposide ± atezolizumab

Stephen Liu, Lombardi Cancer Center, Georgetown University, Washington, DC, USA

Critical analysis and perspectives

Anne-Marie Dingemans, Erasmus MC - University Medical Center, Rotterdam, the Netherlands

Discussion and Q&A (i)

Faculty and online audience

Friday, 18 June 2021

12:00-13:00 CEST (18:00 HKT / 19:00 JST / 20:00 AEST)

Webcast of 17 June presentations, Discussion and Q&A (ii)

Faculty and online audience:

Chair: James CH Yang, National Taiwan University Cancer Center, Taipei, Taiwan

Stephen Liu, Lombardi Cancer Center Georgetown University, Washington, DC, USA

Anne-Marie Dingemans, Erasmus MC - University Medical Center, Rotterdam, the Netherlands

Myung-Ju Ahn, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Hidehito Horinouchi, National Cancer Center - Tsukiji Campus, Chuo-ku,  Japan